Red blood cell transfusion therapy, targeting a goal Hb concentration of 10 g/dL and Hb S < 30%, improves the risk of recurrence to 18% for an overt stroke and 28% for new silent infarcts [24]. This evidence concerns the gene GSTM1 and Stroke.